Results 81 to 90 of about 542 (130)

No Evidence that <i>CD33</i> rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. [PDF]

open access: yesDis Markers, 2022
Castaño-Bonilla T   +29 more
europepmc   +1 more source

Improving sepsis care with Artificial Intelligence. What would Illich say? [PDF]

open access: yesCrit Care Sci
Komorowski M   +4 more
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

open access: yesCancers (Basel)
Solana-Altabella A   +26 more
europepmc   +1 more source

Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy. [PDF]

open access: yesNature
Ng KW   +50 more
europepmc   +1 more source

A Switchable Deep Eutectic System Based on Diarylethene. [PDF]

open access: yesACS Omega
Cruz H   +9 more
europepmc   +1 more source

Cost-effectiveness of procalcitonin-guided antibiotic duration for hospitalized patients with sepsis. [PDF]

open access: yesCrit Care
Stevenson M   +5 more
europepmc   +1 more source

Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

open access: yesPneumonia (Nathan)
Gomes-Silva J   +7 more
europepmc   +1 more source

Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry. [PDF]

open access: yesLeukemia
Alfonso-Pierola A   +49 more
europepmc   +1 more source

Elevating fungal care: bridging Brazil's healthcare practices to global standards. [PDF]

open access: yesMicrobiol Spectr
Salmanton-García J   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy